Kevin Ali, Organon CEO
Organon's Humira biosimilar gets exclusive spot on VA formulary
AbbVie’s Humira is getting swapped out for Organon’s biosimilar Hadlima on the US Department of Veterans Affairs’ national formulary.
The move marks a big win …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.